George Cusatis
Impact in
- Oncology top 10%
- Drug Transport and Resistance Mechanisms
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Cancer therapeutics and mechanisms 2
- PI3K/AKT/mTOR signaling in cancer 2
- Protein Degradation and Inhibitors 1
- Oncology 6
- Drug Transport and Resistance Mechanisms 4
- Pancreatic and Hepatic Oncology Research 2
- Co-authors
- Alex Sparreboom (4 shared papers)Manuel Hidalgo (6 shared papers)Sharyn D. Baker (3 shared papers)Susan E. Bates (2 shared papers)Roxann Ingersoll (2 shared papers)Jaap Verweij (2 shared papers)Julie R. Brahmer (1 shared paper)Robert W. Robey (1 shared paper)
- Journals
- Molecular Cancer Therapeutics (1 paper)Cancer Biology & Therapy (1 paper)JNCI Journal of the National Cancer Institute (1 paper)Neoplasia (1 paper)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesNetherlandsItaly
In The Last Decade
George Cusatis
8 papers receiving 507 citations
Peers
Comparison fields: 5 of 65
- Oncology 414
- Pharmacology 86
- Pediatrics, Perinatology and Child Health 100
- Pulmonary and Respiratory Medicine 137
- Hematology 32
Countries citing papers authored by George Cusatis
This map shows the geographic impact of George Cusatis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George Cusatis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George Cusatis more than expected).
Fields of papers citing papers by George Cusatis
This network shows the impact of papers produced by George Cusatis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George Cusatis. The network helps show where George Cusatis may publish in the future.
Co-authors
The 25 scholars most cited alongside George Cusatis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 180 | |
| 2 | 2007 | 147 | |
| 3 | 2005 | 62 | |
| 4 | 2008 | 51 | |
| 5 | 2012 | 43 | |
| 6 | 2007 | 20 | |
| 7 | 2006 | 12 | |
| 8 | In vivo testing of Mycophenolic acid (MPA) in primary pancreatic cancer (PaCa) xenografts | 2007 | 1 |
About George Cusatis
George Cusatis is a scholar working on Molecular Biology, Oncology, Pediatrics, Perinatology and Child Health, Organic Chemistry and Pulmonary and Respiratory Medicine, having authored 8 papers that have together received 516 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (4 papers), Pharmacological Effects and Toxicity Studies (2 papers), Cancer therapeutics and mechanisms (2 papers), Pancreatic and Hepatic Oncology Research (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Cytomegalovirus and herpesvirus research (1 paper), Protein Degradation and Inhibitors (1 paper) and Phagocytosis and Immune Regulation (1 paper). The work is most often cited by research in Oncology (414 citations), Pharmacology (86 citations), Pediatrics, Perinatology and Child Health (100 citations), Pulmonary and Respiratory Medicine (137 citations) and Hematology (32 citations). George Cusatis has collaborated with scholars based in United States, Netherlands and Italy. Frequent co-authors include Alex Sparreboom, Manuel Hidalgo, Sharyn D. Baker, Susan E. Bates, Roxann Ingersoll, Jaap Verweij, Julie R. Brahmer, Robert W. Robey, Jing Li and Eugenio Villa. Their work appears in journals such as Molecular Cancer Therapeutics, Cancer Biology & Therapy, JNCI Journal of the National Cancer Institute, Neoplasia and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.